* Artivion Inc AORT.N reported a quarterly adjusted loss
of 24
cents per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of -5
cents. The mean expectation of five analysts for the quarter
was for a loss of 6 cents per share. Wall Street expected
results to range from -10 cents to 1 cents per share.
* Revenue rose 14.3% to $87.85 million from a year ago;
analysts
expected $84.32 million.
* Artivion Inc's reported EPS for the quarter was a loss
of 24
cents.
* The company reported a quarterly loss of $9.8 million.
* Artivion Inc shares had fallen by 15.0% this quarter and
gained 6.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 12.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Artivion Inc is
$26.00
This summary was machine generated from LSEG data November 2 at
09:58 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.06 -0.24 Missed
Jun. 30 2023 -0.08 -0.07 Beat
Mar. 31 2023 -0.14 -0.33 Missed
Dec. 31 2022 -0.12 0.05 Beat